Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Turquie And NotKarel Joyce Kalaw

List of bibliographic references

Number of relevant bibliographic references: 27.
Ident.Authors (with country if any)Title
000477 Hasan Mandal [Turquie]Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic
000526 Mayda Gursel [Turquie] ; Ihsan Gursel [Turquie]Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
000611 Rozhgar A. Khailany [Iraq] ; Muhamad Safdar [Pakistan] ; Mehmet Ozaslan [Turquie]Genomic characterization of a novel SARS-CoV-2
000680 Ilhami Çelik [Turquie] ; Esma Saatçi [Turquie] ; Ay Egül Füsun Eyübo Lu [Turquie]Emerging and reemerging respiratory viral infections up to Covid-19
000751 Burcin Halacli [Turquie] ; Akin Kaya [Turquie] ; Arzu Topeli [Turquie]Critically-ill COVID-19 patient.
000762 Mustafa Hasöksüz [Turquie] ; Selçuk Kiliç [Turquie] ; Fahriye Saraç [Turquie]Coronaviruses and SARS-COV-2
000764 Ümit Türsen [Turquie] ; Belma Türsen [Turquie] ; Torello Lotti [Italie]Coronavirus-Days in Dermatology.
000850 Fatih Ha Lak [Turquie] ; Mehmet Y Ld Z [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Özgür Kasapçopur [Turquie]Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
000F96 Hakan Leblebicioglu [Turquie] ; Alfonso J. Rodriguez-Morales [Colombie] ; Gian Maria Rossolini [Italie] ; Rogelio L Pez-Vélez [Espagne] ; Jean-Ralph Zahar [France] ; Jordi Rello [Espagne]Management of infections in critically ill returning travellers in the intensive care unit—I: considerations on infection control and transmission of resistance☆
001201 Fatma Bayrakdar [Turquie] ; Ay E Ba Ak Alta ; Gülay Korukluo Lu ; Selmur Topal[Molecular diagnosis and phylogenetic analysis of the first MERS case in Turkey].
001A49 Saliha D. Durmu Tekir [Turquie] ; Kutlu Ülgen [Turquie]Systems biology of pathogen‐host interaction: Networks of protein‐protein interaction within pathogens and pathogen‐human interactions in the post‐genomic era
001B44 Yasin Ahin [Turquie]A Tool for Comparing Outbreak Detection Algorithms
001E04 Suleyman Aydin [Turquie] ; Tumer Guven [Turquie] ; Brahim Sahin [Turquie] ; Aziz Aksoy [Turquie] ; Yalç N Kendir [Turquie] ; Mustafa N. Lhan [Turquie] ; Cihan Citil [Turquie] ; Zekiye Catak [Turquie] ; Cemal Ustun [Turquie]The effects of fever on hormone ghrelins, immunoglobulins, and heat shock protein 70 expression after swine flu vaccinations
001E88 Hayati Beka [Turquie] ; Ayse Kilic [Turquie] ; Emin Unuvar [Turquie] ; Mustafa Onel [Turquie] ; Fatma Oguz [Turquie] ; Mujgan Sidal [Turquie] ; Seyhan Aslan [Turquie] ; Emel Bozkaya [Turquie] ; Selim Badur [Turquie] ; Ali Agacfidan [Turquie]Frequency of Common Viruses in Etiology of Acute Respiratory Tract Infections
002403 Emrah Ruh [Turquie][Recent developments in SARS vaccine studies].
003153 Murat Civaner [Turquie] ; Berna Arda [Turquie]Can "presumed consent" justify the duty to treat infectious diseases? An analysis
003240 Nazim Dogan [Turquie] ; Behzat Özkan [Turquie] ; Brahim Boga [Turquie] ; Mehmet Kizilkaya [Turquie] ; Hakan Altinda [Turquie]A Succesful Treatment of Avian Influenza İnfection in Turkey
003325 Elcin Yoldascan [Turquie] ; Behice Kurtaran [Turquie] ; Melik Koyuncu [Turquie] ; Esra Koyuncu [Turquie]Modeling the Economic Impact of Pandemic Influenza: A Case Study in Turkey
003B11 Anastasia N. Vlasova [États-Unis] ; XINSHENG ZHANG [États-Unis] ; Mustafa Hasoksuz [Turquie] ; Hadya S. Nagesha [États-Unis] ; Lia M. Haynes [États-Unis] ; YING FANG [États-Unis] ; SHAN LU [États-Unis] ; Linda J. Saif [États-Unis]Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nudeoprotein
004969 Jeffrey L. Arnold [États-Unis] ; Louise-Marie Dembry [États-Unis] ; Ming-Che Tsai [République populaire de Chine] ; Nicholas Dainiak [États-Unis] ; Ülküen Rodoplu [Turquie] ; David J. Schonfeld [États-Unis] ; Vivek Parwani [États-Unis] ; James Paturas [États-Unis] ; Christopher Cannon [États-Unis] ; Scott Selig [États-Unis]Recommended Modifications and Applications of the Hospital Emergency Incident Command System for Hospital Emergency Management
005605 N. Seyrek ; M. Balal ; I. Karayaylali ; S. Paydas ; K. Aikimbaev ; S. Cetiner ; G. Seydaoglu [Turquie]Which Parameter Is More Influential on the Development of Arteriosclerosis in Hemodialysis Patients?
005716 F. N. Özdemir [Turquie] ; F. B. Atac [Turquie] ; A. Akçay [Turquie] ; N. Ozbek [Turquie] ; M. Haberal [Turquie]Role of Genetic Factors in Vascular Access Thrombosis in Hemodialysis Patients
005748 I. Karayaylali ; N. Seyrek ; M. Balal ; S. Paydas ; S. Cetiner ; A. Yaman [Turquie]Pre‐ and Post Hemodialysis Procalcitonin Levels and Their Relationships with Immunoregulatory, Proinflammatory Cytokines in Chronic Hemodialysis Patients
005826 N. Seyrek ; M. Balal ; I. Karayaylali ; S. Paydas ; K. Aikimbaev ; S. Cetiner ; G. Seydaoglu [Turquie]Is There Any Relationship between Serum Levels of IL‐10 and Atherosclerosis in Hemodialysis Patients?
005934 S. Sezer ; E. Kulah ; F. N. Özdemir ; E. Tutal ; Z. Arat ; M. Haberal [Turquie]Clinical Consequences of Intermittent Elevation of C‐Reactive Protein Level in Hemodialysis Patients
006718 Hadis Fathizadeh ; Parham Maroufi [Iran] ; Mansooreh Momen-Heravi [Iran] ; Sounkalo Dao [Mali] ; Kran Köse [Turquie] ; Khudaverdi Ganbarov ; Pasquale Pagliano [Italie] ; Silvano Esposito [Italie] ; Hossein Samadi Kafil [Iran]Protection and disinfection policies against SARS-CoV-2 (COVID-19).
006761 Mahdi Asghari Ozma [Iran] ; Parham Maroufi [Iran] ; Ehsaneh Khodadadi [Iran] ; Kran Köse [Turquie] ; Isabella Esposito [Italie] ; Khudaverdi Ganbarov ; Sounkalo Dao [Mali] ; Silvano Esposito [Italie] ; Tuba Dal [Turquie] ; Elham Zeinalzadeh [Iran] ; Hossein Samadi Kafil [Iran]Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021